Weiss Ratings Reiterates Sell (E+) Rating for 10x Genomics (NASDAQ:TXG)
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports. TXG has been the topic of a number of other research reports. Leerink Partners downgraded 10x Genomics from an “outperform” rating to a “market perform” rating and […]
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports. TXG has been the topic of a number of other research reports. Leerink Partners downgraded 10x Genomics from an “outperform” rating to a “market perform” rating and […]
